Montelukast sodium powder Raw Materials CAS 151767-02-1

MF:C35H37ClNNaO3S

MW:610.18

EINECS:604-813-7

Specification:Montelukast sodium powder

Sample:Montelukast sodium powder

Brand:Montelukast sodium powder

Appearance: powder

Storage: Cool Dry Place

Brand: chemical Raw Materials

Shelf Life: 2 Years

Test Method: HPLC

Uses and synthesis of Montelukast sodium powder

Montelukast sodium powder. Common dosage forms are tablets, granules, chewable tablets. For the prevention and long-term treatment of asthma. Montelukast sodium is an orally effective selective leukotriene receptor antagonist, which can specifically inhibit cysteylleukotriene receptors, and was successfully developed by Merck in Germany and launched in Canada, Finland and Mexico in 1997. Montelukast sodium is suitable for the prevention and long-term treatment of asthma in adults and children, including the prevention of daytime and nighttime asthma symptoms, the treatment of aspirin-sensitive asthma patients, and the prevention of exercise-induced bronchoconstriction, Montelukast sodium may also be used to relieve symptoms of seasonal allergic rhinitis in patients 15 years of age and older who have not responded to or are intolerant to other treatments.

Applications/Functions of Montelukast sodium powder

• Montelukast sodium powder is suitable for reducing symptoms caused by allergic rhinitis
• Montelukast sodium is used to relieve symptoms caused by allergic rhinitis
• Montelukast sodium is used for a variety of conditions, including asthma, exercisable bronchospasm, allergic rhinitis, primary dysmenorrhea, and urticaria.
• Montelukast sodium powder is primarily used as a supplemental treatment for inhaled corticosteroids in adults if they do not bring the desired effect when used alone.
• Montelukast sodium powder is also used to prevent allergic reactions and asthma attacks during intravenous immunoglobulins.

Physicochemical Property of Montelukast sodium powder